These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 21691195)
1. Phosphorylation of GSK-3β mediates intralipid-induced cardioprotection against ischemia/reperfusion injury. Rahman S; Li J; Bopassa JC; Umar S; Iorga A; Partownavid P; Eghbali M Anesthesiology; 2011 Aug; 115(2):242-53. PubMed ID: 21691195 [TBL] [Abstract][Full Text] [Related]
2. Intralipid, a clinically safe compound, protects the heart against ischemia-reperfusion injury more efficiently than cyclosporine-A. Li J; Iorga A; Sharma S; Youn JY; Partow-Navid R; Umar S; Cai H; Rahman S; Eghbali M Anesthesiology; 2012 Oct; 117(4):836-46. PubMed ID: 22814384 [TBL] [Abstract][Full Text] [Related]
3. Ventricular hypertrophy abrogates intralipid-induced cardioprotection by alteration of reperfusion injury salvage kinase/glycogen synthase kinase 3β signal. Ma LL; Ge HW; Kong FJ; Qian LB; Hu BC; Li Q; Xu L; Liu JQ; Xu YX; Sun RH Shock; 2014 May; 41(5):435-42. PubMed ID: 24430545 [TBL] [Abstract][Full Text] [Related]
4. Intralipid protects the heart in late pregnancy against ischemia/reperfusion injury via Caveolin2/STAT3/GSK-3β pathway. Li J; Ruffenach G; Kararigas G; Cunningham CM; Motayagheni N; Barakai N; Umar S; Regitz-Zagrosek V; Eghbali M J Mol Cell Cardiol; 2017 Jan; 102():108-116. PubMed ID: 27847332 [TBL] [Abstract][Full Text] [Related]
5. Morphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK/GSK-3β pathway independent of PI3K/Akt. He SF; Jin SY; Wu H; Wang B; Wu YX; Zhang SJ; Irwin MG; Wong TM; Zhang Y Toxicol Appl Pharmacol; 2015 Nov; 288(3):349-58. PubMed ID: 26296503 [TBL] [Abstract][Full Text] [Related]
6. Remifentanil Preconditioning Reduces Postischemic Myocardial Infarction and Improves Left Ventricular Performance via Activation of the Janus Activated Kinase-2/Signal Transducers and Activators of Transcription-3 Signal Pathway and Subsequent Inhibition of Glycogen Synthase Kinase-3β in Rats. Qiao S; Mao X; Wang Y; Lei S; Liu Y; Wang T; Wong GT; Cheung CW; Xia Z; Irwin MG Crit Care Med; 2016 Mar; 44(3):e131-45. PubMed ID: 26468894 [TBL] [Abstract][Full Text] [Related]
7. Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3beta. Feng J; Lucchinetti E; Ahuja P; Pasch T; Perriard JC; Zaugg M Anesthesiology; 2005 Nov; 103(5):987-95. PubMed ID: 16249673 [TBL] [Abstract][Full Text] [Related]
8. Rosuvastatin protects isolated hearts against ischemia-reperfusion injury: role of Akt-GSK-3β, metabolic environment, and mitochondrial permeability transition pore. Vélez DE; Mestre-Cordero VE; Hermann R; Perego J; Harriet S; Fernandez-Pazos MLM; Mourglia J; Marina-Prendes MG J Physiol Biochem; 2020 Feb; 76(1):85-98. PubMed ID: 31916218 [TBL] [Abstract][Full Text] [Related]
10. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore. Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017 [TBL] [Abstract][Full Text] [Related]
11. G Protein-Coupled Estrogen Receptor 1 Mediates Acute Estrogen-Induced Cardioprotection via MEK/ERK/GSK-3β Pathway after Ischemia/Reperfusion. Kabir ME; Singh H; Lu R; Olde B; Leeb-Lundberg LM; Bopassa JC PLoS One; 2015; 10(9):e0135988. PubMed ID: 26356837 [TBL] [Abstract][Full Text] [Related]
12. Sufentanil postconditioning protects the myocardium from ischemia-reperfusion via PI3K/Akt-GSK-3β pathway. Wu QL; Shen T; Ma H; Wang JK J Surg Res; 2012 Dec; 178(2):563-70. PubMed ID: 22727941 [TBL] [Abstract][Full Text] [Related]
13. Sevoflurane confers additive cardioprotection to ethanol preconditioning associated with enhanced phosphorylation of glycogen synthase kinase-3β and inhibition of mitochondrial permeability transition pore opening. Onishi A; Miyamae M; Inoue H; Kaneda K; Okusa C; Inamura Y; Shiomi M; Koshinuma S; Momota Y; Figueredo VM J Cardiothorac Vasc Anesth; 2013 Oct; 27(5):916-24. PubMed ID: 23266287 [TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling. Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553 [TBL] [Abstract][Full Text] [Related]
15. From local to global: lipid emulsion (intralipid) makes a move. Kawaraguchi Y; Roth DM; Patel HH Anesthesiology; 2011 Aug; 115(2):226-8. PubMed ID: 21654493 [No Abstract] [Full Text] [Related]
16. Sphingosine 1-Phosphate Postconditioning Protects Against Myocardial Ischemia/reperfusion Injury in Rats via Mitochondrial Signaling and Akt-Gsk3β Phosphorylation. Fang R; Zhang LL; Zhang LZ; Li W; Li M; Wen K Arch Med Res; 2017 Feb; 48(2):147-155. PubMed ID: 28625317 [TBL] [Abstract][Full Text] [Related]
17. Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK. Jeong CW; Yoo KY; Lee SH; Jeong HJ; Lee CS; Kim SJ J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):387-94. PubMed ID: 22396328 [TBL] [Abstract][Full Text] [Related]
18. Bradykinin prevents reperfusion injury by targeting mitochondrial permeability transition pore through glycogen synthase kinase 3beta. Park SS; Zhao H; Mueller RA; Xu Z J Mol Cell Cardiol; 2006 May; 40(5):708-16. PubMed ID: 16516918 [TBL] [Abstract][Full Text] [Related]
19. Ischaemic post-conditioning protects both adult and aged Sprague-Dawley rat heart from ischaemia-reperfusion injury through the phosphatidylinositol 3-kinase-AKT and glycogen synthase kinase-3beta pathways. Yin Z; Gao H; Wang H; Li L; Di C; Luan R; Tao L Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):756-63. PubMed ID: 19207715 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological postconditioning against myocardial infarction with a slow-releasing hydrogen sulfide donor, GYY4137. Karwi QG; Whiteman M; Wood ME; Torregrossa R; Baxter GF Pharmacol Res; 2016 Sep; 111():442-451. PubMed ID: 27378570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]